Market Research Blog

Significant findings from report show that the global rare inflammatory disease treatment market will increase at an assessed 4.4% CAGR during the forecast period, 2017-2026. The report also anticipates that by 2026-end, rare inflammatory disease treatment worth nearly US$ 15,960.8Mn will be witnessed across the globe.

With mounting instances of genetic diseases, demand for therapeutic measures have witnessed a hike, as no effective procedures exist that provide effective treatment of genetic or rare inflammatory diseases.  Chromosomal changes primarily influence prevalence of these diseases. In a bid to curtail the disease prevalence, several pharmaceutical industries have been taking efforts to make advancements in relevant drugs as well as therapeutic methods. For example, new treatment options are being developed by researchers for geriatric and pediatric patients suffering from Still’s disease, which is a rare disease linked with the inflammation of joints.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/REP-GB-6428

Doctors are stepping up their efforts by creating awareness among the patients with regard to benefits of anti-inflammatory drugs, which have been deemed effective in the prevention and control of rare inflammatory diseases. Currently, there is rapid increase in the demand for authorized effective treatments of the rare inflammatory diseases. The OOPD (Office of Orphan Products Development) has been offering incentives to drug companies, supporting the development of treatment methods for these diseases. National Institutes of Health (NIH) are providing immense support for improving patients’ health, by focusing mainly on the development of new treatment methods. Collaborative projects are being initiated by NIH in order to examine the common causes and effects of related diseases.

Increasing Inflammatory & Autoimmune Diseases to Create Opportunities for New Therapies

Several group of scientists have associated cytokine IL-23 with treatment of inflammatory and autoimmune diseases, which in turn is creating new ways of development for therapies. Researchers have identified a fundamental molecular mechanism essential to inflammatory and autoimmune diseases such as multiple sclerosis, rheumatoid arthritis and psoriasis. The action of pro-inflammatory cytokine IL-23, depends on the organizational stimulation of its receptor, namely IL-23R.

Moreover, the occurrence of inflammatory and autoimmune diseases is increasing on a rapid pace. Globally, an approximate number of 125 million populace are affected by psoriasis and around 100 million by rheumatoid arthritis annually. The presence of inflammatory bowel infections such as ulcerative colitis and Crohn’s disease is increasing at an alarming rate in formerly unaffected fragments of the world.

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-6428

Key Takeaways from Rare Inflammatory Disease Treatment Market Report for Estimated Period, 2017-2026

• In terms of revenue, North America will remain the largest market for rare inflammatory disease treatment market, closely followed by Europe. Nearly half value share of the market is held by rare inflammatory disease treatment sales in North America and Europe collectively. APEJ will also bolt onto a largest market revenue share, by registering a relatively faster expansion than Europe in the market through 2026.
• On the basis of indication, ulcerative colitis are likely to remain considerably larger than that of the other segments.
• The lion’s share in the global market for rare inflammatory disease treatment is contributed by biologics segment.
• Oral care & Hospital Pharmacies will observe fastest growth during the forecast period.

Key market players outlined by the report is inclusive of Pfizer, Inc., Allergan Plc, Valeant, Johnson & Johnson, Questcor Pharmaceuticals, Inc., Novartis AG, Abbvie, Abbott Laboratories, Regeneron Pharmaceuticals, and Swedish Orphan Biovitrum AB.

Why Future Market Insights?

•   Comprehensive analysis on evolving purchase pattern across different geographies
•   Detailed insights of market segments and sub-segments for historical as well as forecast period
•   A competitive analysis of prominent players and emerging players in the keyword market
•   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Buy Now Report@ https://www.futuremarketinsights.com/checkout/6428 

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

A dental handpiece is an instrument used to hold dental burs, disks, or cups in order to perform tooth removal or to perform cleaning and polishing of teeth or restorative material. The instrument is available in two modalities that includes air driven and electrically driven handpieces. It is powered by either electric motor or air turbines.

This Wearable Blood Pressure Monitor market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Wearable Blood Pressure Monitor market.

Wearable blood pressure monitors are smaller than the traditional blood pressure devices. Most wearable blood pressure monitors are digital and the new smart wearable blood pressure monitors are operated through apps. Wearable blood pressure monitors are available in three basic forms, which are wrist blood pressure monitor, upper arm blood pressure monitor, finger blood pressure monitor. Among all types of wearable blood pressure monitors, the wrist wearable blood pressure monitors are of particular interest due to the easy use and non-bulky look and design. With the advancement in technology the wrist based wearable blood pressure monitors are becoming sleeker and slim such as the recently launched Omron’s Heart Guide. The device looks like a smart watch, and also has the features of a smart watch. The Heart Guide is a step towards in the inclusion of blood pressure monitoring through a fitness tracker. Further advancement in technology for wearable blood pressure monitors is expected to drive the growth and adoption of wearable blood pressure monitor market globally, throughout the forecast period.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-9401

Wearable blood pressure monitor Market: Drivers and Restraints

Increasing prevalence of hypertension, increase in healthcare spending and rise in adoption of wireless and wearable technology are some of the factors that drive the growth of wearable blood pressure monitors. Others factors such as increase in ageing population and rise in cardiovascular disorders also drive the growth of wearable blood pressure monitors. However, increased cost of wearable blood pressure monitors, lack of precision when compared to conventional devices and compatibility issues with other devices are some of the factors that may hinder the growth of the wearable blood pressure monitor market.

Wearable blood pressure monitor Market: Overview

Increase in hypertension population is primarily driven by changes in lifestyle and adoption of sedentary lifestyle. The increase in fast pace lifestyle has moved patients from regular visit to doctor to opting the use of compatible, easy to use wearable blood pressure monitors. Wearable blood pressure monitors are currently still being developed from wireless upper arm monitors to bulky wrist monitors to recently FDA approved watch type of blood pressure monitors. With the advancement in technology the adoption of such wearable blood pressure monitors is expected to rise during the forecast period there by driving a significant growth of the wearable blood pressure monitor market.

Request Brochure of Report: https://www.futuremarketinsights.com/reports/brochure/rep-gb-9401

Wearable blood pressure monitor Market: Regional Outlook

North America and Europe take the maximum share of the Wearable blood pressure monitor market. Increased adoption of advance technology, rise in healthcare spending, and increase in awareness in these regions are some of the factors that drive the growth of the Wearable blood pressure monitor market. However Asia Pacific region is expected to have the a significantly high growth rate due to increasing aging population, rise in hypertension patient pool in the region and need for continuous or periodic monitoring of patients.

Wearable blood pressure monitor Market: Key Players

Some of the Key players in the Wearable blood pressure monitor market include, Blipcare, iHealth Labs Inc., OMRON Corporation, Koninklijke Philips N.V., Pyle Audio, ForaCare Suisse AG, Qardio, Inc., Xiaomi, Medaval Ltd., Nokia Corporation, Koogeek Inc., and Inventum Huishoudelijke Apparaten B.V., among many others.

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-9401

Wearable blood pressure monitor Market: Segmentation

The global Wearable blood pressure monitor market is segmented by product type, indication, end users and region:

According to a recent study by Future Market Insights (FMI), sales of infection prevention products are expected to top US$ 37.4 Bn in 2021, at a CAGR of over 4.2% during the forecast period (2021-2031).

Growing prevalence of acute kidney injury as well as increasing early diagnosis with subsequent increasing treatment seeking rate are the prime drivers of the global acute kidney injury treatment market. Treatment such as dialysis therapies has resulted in better management of acute kidney injury, and has helped reduce the risk of various kidney-related diseases. Various organisations are involved in acute kidney injury disease surveillance. In 2017, China’s central government issued the 13th Five Year National Science and Technology Innovation Plan, which aims to create a national platform to share biomedical big data, develop technologies for precision medicine, and integrate them into a multilevel knowledge database, leading the healthcare treatment market to new growth avenues.

Femtech is a term used for female technology which involves the use of digital health tools including software, diagnostics, products, and services that are targeted at women’s health. According to a recent Future Market Insights (FMI) report, the global femtech market is estimated to hit a valuation of US$ 948.1 Mn in 2021, with a market CAGR of 15.0% during the forecast period (2021-2031).

Increasing incidence of pneumococcal diseases such as pneumonia, meningitis, and bacteremia is driving the market growth. According to a report published by Centers of Disease Control and Prevention in 2018, over 150,000 people in the U.S. are required emergency medical assistance due to pneumonia and approximately 3,500 deaths are reported in the country because of bacteremia and meningitis.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-7078

Kids under the age of 5 years and adult over 65 years of age a more vulnerable to pneumococcal diseases. Pneumococcal vaccines plays a significant role in safeguarding people and also assist in the treatment of these diseases. Thus, the demand to curb the rising incidence of pneumonia is expected to create lucrative growth opportunities for the market.

Government and various organization such as UNICEF, the WHO, and others across the globe are taking initiatives to spread the awareness and reduce the burden of pneumococcal diseases. Attributed to this, the public health agencies is expected to remain the dominant the distribution channel segment over the next ten years.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-7078

Key Takeaways from FMI’s Pneumococcal Vaccines Market Study

• The U.S. is anticipated to dominate the North America market on the back of high prevalence of pneumococcal diseases
• The market in the U.K. is likely to grow at a steady pace, owing to the presence of leading market player in the country.
• India will emerge as a highly lucrative market favored by the increasing number of government initiatives to curb the prevalence of pneumococcal diseases
• Due to large pool of coronavirus and number of medical institutes and hospitals in China, the market in the country is likely to project rapid growth.
• Based on product type, pneumococcal conjugate vaccines is estimated to lead the segment, supported by the increasing number of children vaccination programs.

“Several healthcare institutes, research centers, and leading manufacturers are focusing on research and development (R&D) and clinical trials for developing novel pneumococcal drugs to address the demand for vaccines for multiple serotypes. Their efforts are estimated to bode well for the market, spurring the sales,” says the FMI analyst.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-7078

Competitive Landscape

Leading players operating in the pneumococcal vaccines landscape are increasingly investing in research and development and conducting clinical trial for developing novel pneumococcal drugs. Besides this, some of the market players are focusing on receiving approvals from regulatory bodies to launch the products. For instance,

In January 2021, Pfizer Inc,, one of the leading pharmaceutical company, announced receiving an approval from the U.S. Food and Drug Administration (FDA) for its new drug named, PREVNAR 20. It is a pneumococcal conjugate vaccines for prevention of invasive disease and pneumonia caused by 20 pnemococcus stereotypes in adults aged 18 years or older.

Future Market Insights has published a new report titled “On-site Preventive Care Market: Global Industry Analysis (2017-2021) and Opportunity Assessment (2022-2028).” The report states that the standards set in the workplace for the safety of workers and the need to adhere to workplace norms have triggered the demand for on-site preventive care. Moreover, the increasing incidences of workplace illness has also made it an obligation for employers to follow employee safety codes and adopt on-site preventive care. As a result, the global On-Site Preventive Care Market is expected to witness a CAGR of 7.1% from 2022 to 2028. The market was worth around US$ 16,135 Mn in 2022 and is likely to touch a valuation of US$ 32,063 Mn approximately by the end of 2028.

On-site clinics enable employees to receive the required essential care at the time of emergency without having to leave the workplace. The clinicians in these clinics also aid employees in searching for a primary care physician who they can consult with on a regular basis. As a Future Market Insights analyst quotes, “Changes in lifestyle among the working class have incessantly impelled employers to establish certain behavioural standards within the workplace. This is one of the core factors responsible for the growing adoption of on-site preventive care in several organisations across the globe.”

To remain ‘ahead’ of your competitors, request for a sample-  https://www.futuremarketinsights.com/reports/sample/rep-gb-5518

Burgeoning Penetration of Workplace Wellness Programmes to Bode Well for the Market

In the recent past, workplace wellness programmes have earned the merit of being one of the most adopted healthcare services in the world. It has been further expected that its adoption will increase in the coming years owing to the implementation of the Affordable Care Act. This act is expected to promote an increase in the employee-based coverage of workplace wellness and also promote these programmes through several provisions. Moreover, the growing incidences of chronic diseases among the working population have also become a matter of concern and this has compelled employers across the globe to adopt as well as promote workplace wellness programmes.

Furthermore, employers who have adopted on-site preventive care services have reported enhanced performance ranging from heightened morale and cost savings to productivity. The death of time, access, and cost along with misunderstanding of the benefits of prescribed wellness programmes result in the underutilisation of primary care services. As a result, employees flood emergency rooms, missing out on critical preventive care measures and also leave chronic conditions go unmanaged. In this regard, on-site clinics provide employees with the necessary support without having to leave their work and plus the clinicians also work together with the patients in a cohesive environment to address their various health related issues.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-5518

North America and Western Europe to Compete Neck and Neck

In 2017, North America held a share of 37.0% in the global on-site preventive care market closely trailed by Western Europe. The dominance of North America can be attributed to the several policies implemented by the U.S. government pertaining to employee safety and the adoption of certain employee codes of safety. The U.S. is also an extremely mature market owing to the high adoption of workplace wellness programmes.

Companies to Innovate Services in the Global Market

In order to stay ahead of the competition, several companies operating in the global market are focussing on innovating their existing services and integrating new services. Some of the leading companies in the market are Premise Health, OnSite Care, Inc., PrevMED, RepuCare, Healthcare Solutions Centers, LLC, McCormack & Kale Motiva Health & Chiropractic, Inc., Marino Wellness, Kinema Fitness, and TotalWellness.

Reasons to Buy the report

• We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
• Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.

• The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

For in-depth competitive analysis, Buy Now-  https://www.futuremarketinsights.com/checkout/5518

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Until late 2016, the key focus of most leading players in the 3D printed medical devices market was geographic expansion through acquisition and merger. In May 2016, Johnson & Johnson announced collaboration with a subsidiary of HP Inc. for manufacturing personalized healthcare solutions at reduced costs through 3D printing techniques. J&J collaborated with Organovo to carry out feasibility study on bio printed human tissue for testing new medications to work with Carbon 3D, famous for ultra-fast Continuous Liquid Interface Production (CLIP) technology for production of custom surgical devices.
The focuse is now gradually shifting towards expansion through strategic partnerships to improve their distribution network. For instance, in 2017, Envision partnered with ScanSource, Inc. to deliver 3D printing solutions to resellers in the Americas. Similarly, in 2018, 3D Systems and Stryker announced distribution partnership for VSP (Virtual Surgical Planning) and anatomical models for carniomaxillofacial specialty.

Currently heading towards a market value of over US$ 440 Mn, the global market for 3D printed medical devices is projected for stupendous growth at 16% CAGR during 2019 – 2029. North America will remain the leading market for 3D printed medical device sales, whereas the market attractiveness of Asia Pacific has been rising notably.

To remain ‘ahead’ of your competitors, request for a sample
The market growth is primarily assisted by advancements in 3D printing technology, surging government spending in healthcare sector, increasing usage of 3D printed medical devices for medical procedures, and relative simplification of the manufacturing process of 3D printed medical devices. Introduction of Computer-aided Design (CAD) for 3D printing can create trail ready devices, thereby reducing manufacturing time, time to market as well as operational cost.

Key Takeaways – 3D Printed Medical Devices Market Study

• Although metals and alloys are most preferably used for 3D printed medical devices, biomaterial inks are expected to gain traction during the forecast period owing to their highly biocompatible and versatile physical properties.
• PolyJet – InkJet 3D printing technology currently holds maximum share of 3D printed medical devices market. However, consistent development and adoption of innovative technologies may reduce the 3D printed medical devices market share of this technology during the forecast period.
• Use of 3D printing technology in orthopedic implants is shaping the future of 3D printed medical devices market. It currently accounts for nearly half of the market value.
• The consistently expanding patient pool and growing preference for personalized implants in joint replacement surgeries will remain key boosters to growth of 3D printed medical devices demand in orthopedics.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1501

3D PRINTED MEDICAL DEVICES MARKET STRUCTURE ANALYSIS

• Key players are focusing on strengthening their position by establishing new facilities in North America. In order to increase their revenue share, major players in North America are entering into agreements with hospitals and academic institutes.

• Various manufacturers are targeting Asia and Europe through distribution agreements with local players.

• Some of the key players in the 3D printed medical devices market include

1. 3D Systems, Inc.,
2. EnvisionTEC, and
3. EOS GmbH Electro Optical Systems among others.

• Large medical device manufacturers are increasingly gaining interest in 3D technology for manufacturing. These medical device companies are thus investing in 3D technology through acquisitions. For an instance, GE Healthcare acquired 95% of share of Arcam AB in December 2017.

Learn More About Report Inclusions
Future market insights offers a unique perspective and actionable insights on 3D printed medical devices market in its latest study, presenting historical demand assessment from 2014 – 2018 and projections from 2019 – 2029 based on application (orthopedic implants, dental implants, carnio-maxillofacial Implant), material type (metals and alloys, biomaterial inks and plastics) technology (stereolithography (SLA) – liquid-based 3D printing, selective layer sintering (SLS) – powder-based 3d printing, digital light processing(DLP), fused deposition modelling (FDM)-plastic filament extrusion-based, polyjet – inkjet 3D printing, electronic beam melting (EBM) ) end user (hospitals, ambulatory surgical centers, diagnostic centers) in seven key regions.

For in-depth insights, Download a PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1501

3D PRINTED MEDICAL DEVICES MARKET TAXONOMY

FMI’s study on the 3D printed medical devices market offers information divided into five important segments – application, material type, technology, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Application

• Orthopedic Implants
• Dental Implants
• Carnio-Maxillofacial Implant

Material Type

• Metals and Alloys
• Biomaterial Inks
• Plastics

Technology

• Stereolithography (SLA) – Liquid-based 3D Printing
• Selective Layer Sintering (SLS) – Powder-based 3D Printing
• Digital Light Processing(DLP)
• Fused Deposition Modelling (FDM)-Plastic Filament Extrusion-based
• PolyJet – InkJet 3D Printing
• Electronic Beam Melting (EBM)

End User

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers

Region

• North America
• Latin America
• Western Europe
• Eastern Europe
• APEJ
• JAPAN
  • Middle East and Africa

 

Increasing adoption of label-free detection techniques over labelled detection techniques is due to their cost-effective nature. Additionally, the availability of versatile products coupled with surface plasmon resonance to enhance the specificity of tests is an important factor that will bolster the demand for surface plasmon resonance. Imaging systems help in increasing throughput at a remarkable speed and with precise motion and consistency in report generation. Furthermore, the introduction of multifunctional products for improved outcomes is also expected to drive the growth of the surface plasmon resonance market over the forecast period.

The global surface plasmon resonance market is projected to reach a market value of US$ 770 Mn in 2019, increasing at a decent CAGR of 6% over the forecast period of 2019 – 2029.

“Increasing application of surface plasmon resonance in the field of drug discovery and medical imaging is contributing to the growth of the surface plasmon resonance market. Development of new technologies coupled with surface plasmon resonance, such as nanoparticle surface plasmon resonance and microfluidics, is playing an important role in the overall growth of the global surface plasmon resonance market.”

Get Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-962

Key Takeaways of Surface Plasmon Resonance Market Study

• The market share of imaging systems is evaluated to grow at a significant rate by the end of 2029, as these are the ideal solution for the analysis of label-free and multiplexed biomolecules.
• Sales of surface plasmon resonance are envisaged to be higher in North America. Increasing adoption of imaging systems and biosensors in life science R&D is anticipated to boost the growth of the surface plasmon resonance market in the region.
• Innovation while developing imaging software used in surface plasmon resonance for the analysis of kinetic parameters of biomolecular interactions is a key aspect for increasing the reproducibility of results. Companies are investing in R&D initiatives to introduce superior imaging devices with enhanced magnification, to observe the smallest deflection in the refractive index, thus aiding the growth of the surface plasmon resonance market.

Any Queries, ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-962

Adoption of Label-free Detection Technique for Analysis of Biomolecules

Detection of biological analytes through their physical properties is difficult. As a result, researchers rely on the addition of some sort of label to one or more of the analytes that need to be studied. Inclusion of this label for increasing specificity and accuracy has increased the cost of reagents and assays. To reduce assay cost and complexity while providing more qualitative information through labelled detection, adoption of the label-free detection technique such as surface plasmon resonance has increased, and is expected to fuel the growth of the global surface plasmon resonance market during the forecast period. The label-free detection technique simplifies the procedure by reducing the time and effort required for the development of the assay. Thus, increasing adoption of label-free detection techniques over labelled detection is expected to boost the growth of the global surface plasmon resonance market.

Want more insights?

The surface plasmon resonance market report, a new study by Future Market Insights, opines on the evolution of the global surface plasmon resonance market from 2014–2018, and presents demand projections for 2019–2029, on the basis of product type (imaging systems, sensor systems, and reagents), application (drug delivery, material science, and biosensors), and end user (academic and research institutes, food and beverage industry, biopharmaceutical companies, CROs, and others), across seven prominent regions.

Buy Industry Research Report @ https://www.futuremarketinsights.com/checkout/962

Reasons to Buy the report

• We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
• Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.

• The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.